Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Faten Aberra

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Inflammatory Bowel Diseases|October 22, 2005
Synergy in a synbiotic?Faten Aberra
Digestive Diseases and Sciences|January 22, 2013
Vitamin d deficiency is associated with ulcerative colitis disease activityStacey Blanck, Faten Aberra
Gastroenterology|July 20, 2010
Is it time for dosing anti-TNF antibody therapy by serum level?Caroline Kerner, Faten Aberra
Gastroenterology|March 29, 2011
VSL#3 for ulcerative colitis: growing evidence?Frank I Scott, Faten Aberra
Gastroenterology & Hepatology|March 14, 2017
Utility of the Nonabsorbed (<0.4%) Antibiotic Rifaximin in Gastroenterology and HepatologyChinyu G Su, Faten Aberra, Gary R Lichtenstein
Expert Opinion on Biological Therapy|July 10, 2013
Teduglutide in Crohn's diseaseWojciech Blonski, Anna M Buchner, Faten Aberra, et al.
Journal of Crohn'S & Colitis|March 29, 2022
Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel DiseaseNabeel Khan, Chinmay Trivedi, Faten Aberra, et al.
Pain|April 5, 2002
Spiritual healing as a therapy of chronic pain: a randomized, clinical trialWorth Everett, Faten Aberra, Gregory Bisson, et al.
Scandinavian Journal of Gastroenterology|June 24, 2008
Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?Wojciech Blonski, Rabi Kundu, James Lewis, et al.
Scandinavian Journal of Gastroenterology|June 28, 2008
High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitisWojciech Blonski, Rabi Kundu, Emma F Furth, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Inflammatory Bowel Diseases|October 22, 2005
Synergy in a synbiotic?Faten Aberra
Digestive Diseases and Sciences|January 22, 2013
Vitamin d deficiency is associated with ulcerative colitis disease activityStacey Blanck, Faten Aberra
Gastroenterology|July 20, 2010
Is it time for dosing anti-TNF antibody therapy by serum level?Caroline Kerner, Faten Aberra
Gastroenterology|March 29, 2011
VSL#3 for ulcerative colitis: growing evidence?Frank I Scott, Faten Aberra
Gastroenterology & Hepatology|March 14, 2017
Utility of the Nonabsorbed (<0.4%) Antibiotic Rifaximin in Gastroenterology and HepatologyChinyu G Su, Faten Aberra, Gary R Lichtenstein
Expert Opinion on Biological Therapy|July 10, 2013
Teduglutide in Crohn's diseaseWojciech Blonski, Anna M Buchner, Faten Aberra, et al.
Journal of Crohn'S & Colitis|March 29, 2022
Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel DiseaseNabeel Khan, Chinmay Trivedi, Faten Aberra, et al.
Pain|April 5, 2002
Spiritual healing as a therapy of chronic pain: a randomized, clinical trialWorth Everett, Faten Aberra, Gregory Bisson, et al.
Scandinavian Journal of Gastroenterology|June 24, 2008
Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?Wojciech Blonski, Rabi Kundu, James Lewis, et al.
Scandinavian Journal of Gastroenterology|June 28, 2008
High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitisWojciech Blonski, Rabi Kundu, Emma F Furth, et al.
Pageof 2